3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer Pharmaceutical Investing
Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance Longevity Investing
Fulgent Genetics Slides 27 Percent in Q4 2017 Financial Results, Remains Positive for 2018 Genetics Investing
Avalon GloboCare Teams up with Weill Cornell Medicine to Establish Joint Translational Research Initiative Genetics Investing
Mesoblast Operational Highlights and Financial Results for the Half-Year Ended December 31, 2017 Genetics Investing